Physician profile
Anna Malcolm
NPI 1467957159
$1,348.20
in general payments reported to CMS, 2019-2025
20 companies · $489 in 2025
The $489 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $132 · 2023: $488 · 2024: $240 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $239.49 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $198.65 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $148.73 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $140.12 | 2022-2025 | |
| Abbvie INC. | $117.83 | 2022-2023 | |
| Exeltis, USA INC. | $91.14 | 2023-2025 | Slynd |
| Organon LLC | $67.83 | 2023-2025 | Nexplanon, Jada System |
| Agile Therapeutics, INC. | $62.00 | 2022-2024 | Twirla |
| Galderma Laboratories, L.P. | $39.93 | 2025 | |
| Ethicon US, LLC | $34.76 | 2024 | Surgicel Nu-Knit |
| Cgg Medical INC | $30.88 | 2025 | |
| Roche Diagnostics Corporation | $30.00 | 2022 | |
| Myovant Sciences INC. | $28.70 | 2022 | |
| Solventum Corporation | $18.20 | 2025 | Prevena |
| Amgen INC. | $17.48 | 2024 | Prolia, Evenity |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $17.12 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $17.12 | 2023 | |
| Sage Therapeutics, LLC | $16.22 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $16.22 | 2025 | Qelbree |
| Millicent US INC | $15.78 | 2024 | Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Malcolm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.